Comparison of physiological and perceptual measures of national-level rowing athletes taken during a 10-min submaximal rowing test performed at 95% of 30-min time-trial average pow... by Calvin P. Philp (12095878)

Compatible pollen triggers a decrease in S-RNase transcript levels by a post-transcriptional mechanism. by Bolin Liu (59887)

Mice with a decrease in α7 expression show no behavioral preference to a conditioned odor. by Jennifer L. Hellier (326477)

Antitumor Activity of FGFR Inhibitor as a Result of a Decrease in the Breast TIC Subpopulation In Vivo. by Sungeun Kim (105743)

Decreased sensitivity to Thaxtomin A (TA) in TA-habituated somaclone RB9. by Nathalie Beaudoin (21537)

Atorvastatin decreases proliferation of breast cancer cells more potently than rosuvastatin. by Colin H. Beckwitt (2037196)

Corticosterone treatment decreases MMP-2 promoter activity. by Eric A. Shikatani (131260)

“…MMP-2 mRNA levels were decreased with corticosterone treatment (A) (p = 0.006, n = 5). …”

Diclofenac decreases angiogenesis. by Nina Mayorek (241888)

Beta-catenin signaling is decreased in intermediate progenitor cells. by Christopher A. Mutch (243132)

“…<p>(<b>A</b>) Cortex from E14.5 Axin2-d2EGFP transgenic mice stained for GFP (green), Tbr2 (red), and DNA (blue). …”

Sample velocity profile on an decreasing-frequency (DEC) trial. by Jacob A. Yaffe (8298813)

“…<p>Shown here is the velocity profile from an decreasing-frequency trial of participant # 21, the only participant in this study who had a confirmed diagnosis of FOG. …”

S5 Fig - by Jordan K. Abbott (8934239)

FASN inhibitors result in decreased ΔΨm and increased superoxide production in melan-a cells. by Franco A. Rossato (588513)

FASN inhibitors result in decreased ΔΨm and increased superoxide production in melan-a cells. by Franco A. Rossato (588513)

Multi-way sensitivity analysis on transmission rate, CD4 count at diagnosis, and ART costs in a model-based analysis of Immediate ART initiation in Côte d’Ivoire. by Eric N. Ouattara (6890174)

A low dose of BCNU decreases division and promotes differentiation of O-2A/OPCs by Joerg Dietrich (35101)

A hypoglycaemic <i>milieu</i> decreases NCS viability in a dose-dependent manner. by Shiva Mansouri (2838086)

Knockdown of PODXL expression correlates with decreased cell proliferation. by Zev A. Binder (471251)

Octanoic acid challenge decreases the intracellular pH. by Liam A. Royce (529244)

HC-070 decreases anxiety after CCK-4 treatment in an EPM. by Stefan Just (4811358)

MYCN overexpression leads to decreased <i>id2a</i> expression in early SCG. by Rodrigo Ibarra-García-Padilla (19697623)